Terol La

Product Overview

Terol La is an extended-release medication containing Tolterodine Tartrate as its active ingredient. Designed for gradual absorption, these capsules provide sustained therapeutic effects to manage overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence. By targeting bladder muscle receptors, Terol La helps restore normal bladder function and enhances patients’ daily comfort.

Uses

This medication is primarily indicated for treating OAB syndrome, effectively reducing sudden urges to urinate, frequent bathroom visits, and accidental leakage. Healthcare providers may also prescribe Terol La for other urological conditions requiring bladder muscle relaxation, based on individual patient assessment.

How to Use

Take Terol La capsules whole with water, maintaining a consistent daily schedule. The extended-release formulation requires swallowing intact – do not chew, crush, or divide the capsule. Strictly adhere to your physician’s prescribed regimen and never adjust dosage without medical consultation.

How it Works

As an antimuscarinic agent, Tolterodine Tartrate in Terol La competitively inhibits acetylcholine receptors in bladder smooth muscle tissue. This pharmacological action decreases involuntary detrusor contractions, increasing bladder capacity and reducing OAB symptoms while maintaining normal voiding function.

Dosage and Administration

The standard adult dosage is 4mg once daily, with potential adjustments based on therapeutic response and tolerability. Administration timing should remain consistent day-to-day, preferably with morning intake unless otherwise directed by your healthcare provider.

Benefits

Patients experience significant clinical benefits including:
• Reduced urinary urgency episodes
• Decreased incontinence frequency
• Improved bladder control
• Enhanced quality of life
The 24-hour extended-release profile ensures continuous symptom management with single-daily dosing convenience.

Common Side Effects

While generally well-tolerated, some patients may experience:
– Xerostomia (dry mouth)
– Mild constipation
– Transient visual accommodation changes
– Temporary dizziness
These typically diminish with continued use but should be reported if persistent.

Warnings

Important precautions include:
• Disclose complete medical history, especially regarding glaucoma, liver/kidney impairment, or gastrointestinal conditions
• Avoid alcohol due to potential CNS additive effects
• Exercise caution when driving or operating machinery
• Monitor for signs of urinary retention
• Report any allergic reactions immediately

Storage Information

Maintain capsules in original packaging at controlled room temperature (15-30°C). Protect from humidity and direct sunlight. Keep securely closed and out of children’s reach. Properly dispose of expired medication through authorized take-back programs.

Disclaimer:

This information serves educational purposes only and does not constitute medical advice. While we strive for accuracy, content may not encompass all potential interactions or contraindications. Always consult your healthcare provider regarding treatment decisions. This material supports but does not replace professional medical judgment and the essential doctor-patient relationship.